Workers to breathe easier with The Common Good and Mideco alliance
Lung Disease

Workers to breathe easier with The Common Good and Mideco alliance

Tradies exposed to inhaling contaminants while on the job have a new alliance to help tackle the risks of occupational lung disease.

Melbourne based Mideco have launched several innovative products for use at dusty sites to decontaminate tradies who have been exposed to dust. Using a combination of negative and positive pressure, these products aim to remove contaminated particles from clothing.

Workers whose clothing is covered in dust may be 10 times more likely to be at risk of exposure to contaminants.

Midco’s range of Bat products will now also provide financial support to medical research charity The Common Good, an initiative of The Prince Charles Hospital Foundation, based at one of Australia’s largest specialist lung centres.

“We were aware of the efforts of The Common Good to tackle occupational lung disease, particularly the work they are funding in the silicosis space. As a company, we want to be part of meaningful solutions for the community, and this is another way to show just how committed we are to keeping tradies safe,” said Melton White, Director of Mideco.

Lung disease is the greatest threat to the health of tradies. Whether it be cutting engineered stone bench tops, cutting concrete, farmers ploughing their fields or those working in quarries and mines – the number of tradies at risk could be 600,000*.

The Common Good is driving the development of treatments to treat the early stages of silicosis, and in the past year has undertaken patient trials on 15 young stone masons. The treatment is a whole-lung lavage which flushes the lungs with saline, and in turn vacuums the released silica particles. The research team is able to identify the volume of silica before and after the treatment, and the response seen to date from patients is promising.

The Common Good through their fundraising efforts and alliances with companies such as Mideco are looking to expand silicosis research whilst also committing to increasing research into occupational lung diseases.

“We know larger companies across construction, mining and agriculture are making huge investments into the safety of workers, and we now have to address those individual tradespeople who may be taking precautions, and those who have already contracted lung disease. We want to ensure their hard work doesn’t cost them their quality of life” said Michael Hornby CEO of The Common Good.

“Having Mideco join us is a perfect fit – they are providing critically important prevention and with that success, are sharing the profits to save the lives of others”.

For more information on silicosis and the research into occupational lung disease see The Common Good.

To learn more about Mideco and view their products, visit www.midecohse.com

*Safe to Work. Cancer council urges reduction in silica dust exposure. https://safetowork.com.au/cancer-council-urges-reduction-in-silica-dust-exposure/ date accessed: 21/12/2021

Published: December 22, 2021

Related news & events

2024 Tour de Brisbane raises close to $70,000 for transplant research

The Common Good

2024 Tour de Brisbane raises close to $70,000 for transplant research

The 2024 Tour de Brisbane, sponsored by Transurban, was one for the books, raising close to $70,000 for transplant research done right here in Brisbane.

Find out more

Mother-of-four shares story of transplant journey

Patient Stories

Mother-of-four shares story of transplant journey

A Queensland mother who was diagnosed with Idiopathic Pulmonary Fibrosis and Chronic Hypersensitivity Pneumonitis and later received a lung transplant, shares her story here.

Find out more

The journey from the Cycle of Giving to the Tour de Brisbane

The Common Good

The journey from the Cycle of Giving to the Tour de Brisbane

In 2006, Mary and Mal Long started an event called Cycle of Giving to show their gratitude to Mal’s donor family and medical team.

Find out more

Chain Reaction Challenge 2024: Helping Kids visiting The Prince Charles Hospital

The Common Good

Chain Reaction Challenge 2024: Helping Kids visiting The Prince Charles Hospital

In March, dozens of cyclists from Brisbane will take part in a 1000 km cycle in and around Adelaide for the Chain Reaction Challenge 2024.

Find out more

30-year-old heart transplant recipient’s journey to the 2024 Tour de Brisbane

Heart Disease

30-year-old heart transplant recipient’s journey to the 2024 Tour de Brisbane

A Perth father who received a heart transplant three years ago is preparing to take part in the 2024 Tour de Brisbane. Read more about his journey and support his ride here.

Find out more

International Day of Women and Girls in Science 2024

The Common Good

International Day of Women and Girls in Science 2024

This February, we acknowledge International Day of Women and Girls in Science 2024 and some of the remarkable women who are making a difference in STEM.

Find out more

Marfan and Aortopathy Conference Brisbane 2024

The Common Good

Marfan and Aortopathy Conference Brisbane 2024

The Marfan and Aortopathy Conference Brisbane 2024 is on Saturday, April 20, at The Prince Charles Hospital. Click here for more details.

Find out more

What is Marfan Syndrome?

The Common Good

What is Marfan Syndrome?

What is Marfan Syndrome? It affects about 1 in 5000 people across the globe, and for some, it can lead to serious or even life-threatening complications. Learn more here.

Find out more

The Café for The Common Good finds new home at Caboolture Hospital

Social Enterprise

The Café for The Common Good finds new home at Caboolture Hospital

Caboolture Hospital Café: In exciting news, our café has a new home in the hospital’s recently opened Clinical Services Building.

Find out more